# LabCorp Early Development Laboratories Limited. – FDA Inspection, Sep 27, 2019

Source: https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-limited/ab162380-ea21-4607-b002-b89eeee30d60
Source feed: FDA_Inspections

> FDA inspection 1110897 of LabCorp Early Development Laboratories Limited., September 27, 2019. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1110897
- Company Name: LabCorp Early Development Laboratories Limited.
- Inspection Date: 2019-09-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1181799 - 2022-03-09
- [FDA Inspection 1040408 - 2017-12-14](https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-limited/1ae026af-b7dc-43f6-84aa-9583ded5fc9b)
- FDA Inspection 1062207 - 2017-06-15
- FDA Inspection 1011012 - 2017-03-24
- FDA Inspection 893014 - 2014-07-14

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/labcorp-early-development-laboratories-limited/4f0ec845-b78a-440d-b747-30df285f57ad

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c